Pregnant women still getting UTI meds linked to birth defects

January 12, 2018 by Steven Reinberg, Healthday Reporter

(HealthDay)—Urinary tract infections (UTIs) can be problematic for pregnant women and their babies, but so can two antibiotics used to treat these infections, U.S. health officials warn.

The antibiotics—trimethoprim-sulfamethoxazole (Bactrim) and nitrofurantoin (Macrobid)—have been linked to a small risk for in when given in the first trimester.

Despite the risk, many pregnant women are still getting these antibiotics, according to a new report from the U.S. Centers for Disease Control and Prevention.

"Birth defects associated with these drugs include heart, brain and facial defects," said Elizabeth Ailes, a health scientist at the CDC and lead author of the report.

A 3 percent risk of birth defects is associated with all pregnancies, she said. "The increased risks associated with these antibiotics is relatively small, but significant—about two-times," she said.

About 8 percent of pregnant women develop UTIs.

"It's important for women to know, despite the small elevation in birth defects risk, treatment is really important because untreated UTIs can have serious consequences for both the mom and the baby," Ailes said.

Untreated, these infections can lead to babies born at a , babies born prematurely and the development of body-wide infections that can be deadly, she said.

Among privately insured women with UTIs, about 40 percent are being prescribed Bactrim or Macrobid, according to Ailes.

If a UTI can be cured only with either of these drugs, however, they need to be used regardless of the small risk, said Dr. Jill Rabin, chief of ambulatory care, obstetrics and gynecology and head of urogynecology at Northwell Health in New Hyde Park, N.Y.

Rabin also said that these antibiotics, like any other , should be prescribed at the lowest effective dose.

The American College of Obstetricians and Gynecologists recommended in 2011 that such drugs be prescribed in the first trimester of pregnancy only when other drugs would not be an appropriate treatment, according to the CDC report.

However, one problem with the report, Rabin said, is that "we don't know if these medications were prescribed appropriately based on adjusting the dose and type of antibiotic and on the particular bacteria causing the infection."

The 2011 recommendation about not using these to treat UTIs in the first trimester might not have filtered down to all physicians, another doctor noted.

"A number of previous studies have shown that expert guidelines do not always find their way into bedside practice," said Dr. Michael Grosso, chief medical officer at Huntington Hospital in Huntington, N.Y.

One reason for this is the increasing volume of medical literature, which means more new information is available than any physician can read, Grosso said. In addition, he said that doctors may disagree with a guideline.

"Although a physician may avoid these medications when he knows a patient is pregnant, he may not go so far as to order pregnancy testing prior to every prescription, thus leaving open the door to inadvertent use in the setting of pregnancy," Grosso said.

Concerned patients should ask their doctor if prescribed medications are safe if they might be pregnant, he advised.

For their research, Ailes and her colleagues analyzed data on nearly 483,000 women who were pregnant in 2014 and covered by employer-sponsored insurance. The data came from the MarketScan Commercial Database.

Rabin questioned whether the data was representative of prescriptions given all pregnant or whether the finding that these drugs were commonly prescribed applied only to those represented in the database.

"I think it's premature to draw a sweeping conclusion with this study," Rabin said.

The was published Jan. 12 in the CDC's Morbidity and Mortality Weekly Report.

Explore further: Does dosing of drug for mom make a difference for baby's risk of cleft lip, palate?

More information: Elizabeth Ailes, Ph.D., health scientist, U.S. Centers for Disease Control and Prevention; Michael Grosso, M.D., chief medical officer, Huntington Hospital, Huntington N.Y., Jill Rabin, M.D., chief, ambulatory care, obstetrics and gynecology, and head, urogynecology, Northwell Health, New Hyde Park, N.Y.; Morbidity and Mortality Weekly Report, Jan. 12, 2018

The American Pregnancy Association has more on UTIs and pregnancy.

Related Stories

Does dosing of drug for mom make a difference for baby's risk of cleft lip, palate?

December 27, 2017
Taking a higher dose of topiramate during the first three months of pregnancy may increase a baby's risk of cleft lip or cleft palate more than when taking a lower dose, according to a study published in the December 27, ...

Study explores use of ADHD medications during pregnancy and risk of birth defects

December 13, 2017
Adults, including women of reproductive age, are increasingly being prescribed medications to treat Attention Deficit Hyperactivity Disorder (ADHD) but little evidence has been available about whether exposure to these drugs ...

Certain antibiotics during pregnancy may increase risk of birth defects

July 19, 2017
A new study has found links between certain antibiotics during pregnancy and major congenital malformations in newborns.

World's only super-database for pharmaceutical use during pregnancy

January 22, 2015
Should a woman prescribed antidepressants continue taking them while pregnant? The question is fraught—her health and that of her unborn child is at stake. Yet research to help her and her doctor make that decision is incomplete.

Drug used for pain, anxiety may be linked to birth defects

May 18, 2016
A drug commonly used to treat pain, epilepsy, anxiety and other brain health disorders may be associated with an increased risk of major birth defects, according to a study published in the May 18, 2016, online issue of Neurology, ...

Prescription painkillers, widely used by childbearing age women, double birth defects risk

January 22, 2015
More than one-fourth of privately-insured and one-third of Medicaid-enrolled women of childbearing age filled prescriptions for opioid-based (narcotic) painkillers between 2008 and 2012, according to a new analysis published ...

Recommended for you

Alomst 70 percent of 103 genes linked to prenatal death affect the placenta

March 14, 2018
The role of the placenta in healthy fetal development is being seriously under-appreciated according to a new paper published today (14th March). The study was part of the Wellcome Trust-funded "Deciphering the Mechanisms ...

New research shows why babies need to move in the womb

March 12, 2018
Scientists have just discovered why babies need to move in the womb to develop strong bones and joints. It turns out there are some key molecular interactions that are stimulated by movement and which guide the cells and ...

Labour–inducing drugs put to the test

February 27, 2018
Researchers comparing the use of two drugs for pregnant women who do not go into labour shortly after their waters break have found both are reasonable options.

Air pollutants linked to abnormal fetal growth

February 23, 2018
Chinese mothers who were exposed to a high level of certain air pollutants during pregnancy had a higher risk of abnormal fetal growth, according to a new Yale School of Public Health (YSPH) study.

Scientists discover critical molecular biomarkers of preeclampsia

February 21, 2018
Preeclampsia, a sudden pregnancy complication that can interfere with the blood flow to the placenta and possibly to the fetus, can lead to low birth weight, prematurity and even death. It is also a leading cause of maternal ...

Transgender women can breastfeed, first case study shows

February 16, 2018
The first scientific case study has been published describing how a US transgender woman was able to breastfeed her adopted infant by taking hormones that induce lactation.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.